资讯
1 个月
GlobalData on MSNFDA accepts Sobi’s Gamifant application for HLH/MAS treatmentSobi chief medical officer and research and development head Lydia Abad-Franch stated: “HLH/MAS in Still’s disease is a ...
"Not really. We have very young patients, and you can't remain indifferent. But if I'm doing research, I'm basically saying that I don't accept that I don't have an answer. I will learn, understand ...
At only nine weeks old, baby Méabh is battling a life-threatening condition called HLH syndrome - and she now requires urgent medical care in the UK. Méabh was born on January 2, just two days ...
The application was granted Priority Review with a PDUFA date of June 27, 2025. HLH/MAS, a form of HLH, is a severe complication of rheumatic diseases, occurring most frequently in Still’s disease ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果